Define consensus principles of Patient Group engagement from the 3-way (Industry, Patient Group, and Academia) stakeholder perspectives using case studies of success and barriers
Share evidence and key findings from a 3-way stakeholder assessment of Patient Group engagement in the Clinical Trial process
Gain understanding of the FDA Rules of Engagement and various Conflict of Interest (COI) issues
Solicit feedback on evidence to inform recommendations that can further enhance the value to industry, academia and patient groups of mutually beneficial partnerships that engage the patient groups as fully as possible in the complete spectrum of the clinical research enterprise
Solicit feedback on benchmarking, metrics, and value of patient engagement in clinical trials for research sponsors
*The views and opinions expressed in these presentations are those of the individual presenter and should not be attributed to the Clinical Trials Transformation Initiative, or any organization with which the presenter is employed or affiliated.